## **What is a penicillin G benzathine injection?**
Penicillin G benzathine is an injectable suspension used to treat bacterial infections caused by penicillin-sensitive microorganisms. It’s most commonly recognized under the brand name Bicillin L-A®, manufactured by Pfizer. Classified under HCPCS Code J0561, this medication represents 100,000 units per injection and is intended for intramuscular administration only, never intravenous.
The injection is primarily used in the treatment of syphilis, as well as for prophylaxis against rheumatic fever and other infections where prolonged blood levels of penicillin are required. Its long-acting formulation provides extended therapeutic coverage, making it an important maintenance therapy option in cases where ongoing infection control is needed.
Because of its unique pharmacokinetics, penicillin G benzathine is not interchangeable with other types of penicillin injections. Physicians must carefully select the appropriate formulation to ensure safety and effectiveness. The FDA-approved indications highlight its role in managing infections in the absence of resistance and in patients with predominantly antibody defects or related immune concerns, where continuous infection prevention is critical.
This medication is billed as a lump sum purchase under the code description, which simplifies reimbursement for providers while ensuring clear documentation for Medicare and Medicaid services.
## **HCPCS code J0561 documentation requirements**
When billing for HCPCS Code J0561, providers must maintain detailed and accurate documentation to support medical necessity and ensure compliance with Medicare and Medicaid services. Payers typically require the following elements in the patient record:
### **Diagnosis and clinical justification**
The medical record should include the confirmed diagnosis, such as syphilis (ICD-10 codes A51–A53), streptococcal infections, or rheumatic fever prophylaxis, referencing appropriate ICD-10 codes to support claim accuracy.
It must also explain why Penicillin G Benzathine was selected over other antibiotic formulations, highlighting its clinical necessity for the patient’s condition.
### **Dosage and administration details**
Providers must document the total units administered at each encounter, keeping in mind that J0561 represents 100,000 units. The record should specify the intramuscular route of administration and note the exact injection site. Penicillin G Benzathine should never be given intravenously, so proper documentation of IM use is critical.
### **Frequency and duration of therapy**
The documentation must outline the treatment plan, including the date(s) of administration and the intended course of therapy. If repeated injections are required for prophylaxis or ongoing infection control, the frequency and justification should be clearly stated.
### **Supporting clinical notes**
Clinical notes should reflect the patient’s history, such as predominantly antibody defects or a record of recurrent infections. Notes should also verify that contraindications were considered and allergy screenings were performed before administration.
For example, documentation might include: 'Patient diagnosed with early syphilis confirmed by serologic testing; Penicillin G Benzathine selected due to its long-acting properties essential for adherence to treatment guidelines.' Clear clinical notes detailing the patient's condition and rationale help satisfy payer requirements
### **Billing and coding specifics**
The claim must reflect the correct use of modifier codes if additional services were performed, such as an extra pump setup or other administration-related procedures. If other drugs or infusion services were provided, the documentation should reference the following HCPCS codes billed alongside J0561 for clarity and compliance.
Clear, precise documentation helps avoid denials, ensures accurate reimbursement, and provides a thorough clinical picture for patient support and continuity of care.
## **J0561 billing requirements**
- **Dose-based billing**: Each billing unit represents 100,000 units of penicillin G benzathine. Ensure claims accurately reflect the dosage administered in those standardized units.
- **Medicaid rate increase (NC specific)**: Effective February 1, 2024, North Carolina Medicaid increased reimbursement rates for Bicillin L-A® to better support the treatment of syphilis, including congenital syphilis (NC Medicaid, Division of Health Benefits, 2024). Special billing rules apply under the Physician Administered Drug Program (PADP).
- **Medicare coverage**: HCPCS J0561 falls under drugs administered by injection and is typically billed under Medicare Part B. Confirm local carrier coverage policies before billing
- **No DME involvement**: This code covers only the drug; there’s no requirement to bill DME, orthotics, or prosthetics alongside it.
- **Accurate claim submission**: Always pair J0561 with a valid diagnosis code (e.g., syphilis) and supporting documentation to avoid denials. Be cautious about differentiating it from similar codes like J0558 (penicillin G benzathine + procaine) through provider clinical notes (Coding Health, 2024).
## **Other relevant codes**
- **J0558**: Injection, penicillin G benzathine and penicillin G procaine, up to 1,200,000 units
- **J0570**: Injection, penicillin G procaine, up to 600,000 units
### **References**
NC Medicaid, Division of Health Benefits. (2024, February 1). Bicillin® L-A rates increased effective Feb. 1, 2024.https://medicaid.ncdhhs.gov/blog/2024/02/20/bicillinr-l-rates-increased-effective-feb-1-2024
Coding Health (2024, November 24). HCPCS Code J0561: How to bill & recover revenue. https://coding.health/hcpcs-code-j0561/
Frequently asked questions